ISSUE NO. 41 — Immunomodulation Assessments for Clinical Trials: Sophisticated Bioanalytical Approaches to Support Complex Modalities Sep 30, 2024
ISSUE NO. 40 — Analytical Testing: Accurate and Complete Characterization of Your API to Maximize Bioavailability Sep 23, 2024
ISSUE NO. 37 — Quantitative PCR (qPCR) and Droplet Digital (ddPCR) – Leading-Edge Analysis for Your Gene Therapy Programs Oct 4, 2023
ISSUE NO. 35 — Critical Considerations for the Safe and Compliant Manufacture of Highly Potent Drugs Aug 24, 2023